Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DSA6 | ISIN: SE0009807266 | Ticker-Symbol: 6Y1
Frankfurt
03.10.25 | 08:06
1,138 Euro
-0,18 % -0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTEGRUM AB Chart 1 Jahr
5-Tage-Chart
INTEGRUM AB 5-Tage-Chart

Aktuelle News zur INTEGRUM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDuke Capital - Follow-On Investment into Integrum Group Holdings-
25.09.The observation status for Integrum AB is removed101On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a...
► Artikel lesen
18.09.INTEGRUM AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information4
17.09.INTEGRUM AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer1
16.09.OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: FINAL OUTCOME FOR THEIC OFFER BY OSTEOCENTRIC TO THE SHAREHOLDERS OF INTEGRUM: OSTEOCENTRIC DOES NOT COMPLETE THE OFFER3
04.09.INTEGRUM AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly1
01.09.Integrum AB: Stronger positioning paves the way for continued growth75First quarter 2025/26 (May - July) Net sales amounted to SEK 23.8 (18.5) million. Operating loss totalled SEK 12.4 (12.0) million. Profit/loss after tax amounted to SEK -10.0 (-9.4) million. Earnings...
► Artikel lesen
INTEGRUM Aktie jetzt für 0€ handeln
28.08.Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation1
13.08.INTEGRUM AB: Integrum secures top sponsorship title at the Global Collaborative Congress on Osseointegration exclusively for the next three years1
04.08.OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: Offer document relating to the offer to the holders of shares of Integrum published3
22.07.Integrum Bid Committee Recommends Shareholders Accept Takeover Offer From OsteoCentric1
22.07.Integrum AB: Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric135The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC's public takeover offer, based...
► Artikel lesen
22.07.OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: OSTEOCENTRIC ANNOUNCES A RECOMMENDED CASH OFFER OF SEK 44 PER SHARE TO THE SHAREHOLDERS OF INTEGRUM4
16.06.INTEGRUM AB: Integrum terminates agreement with Redeye regarding equity research coverage1
16.06.Integrum AB: Integrum appoints Louise Wåhlin as new Chief Financial Officer166Mölndal, Sweden, June 16th, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on...
► Artikel lesen
03.06.Integrum AB: A rapid shift to full commercial focus86Fourth quarter 2024/25 (February - April) Net sales amounted to SEK 27.1 m (26.1) Operating result amounted to SEK -11.7 m (2.6) Profit/loss after tax amounted to SEK -9.0 m (2.3) Earnings...
► Artikel lesen
30.05.Integrum AB: Invitation to the Fourth Quarter 2024/25 Results Presentation1
21.05.INTEGRUM AB: Integrum has signed an agreement with Bionics Group Ukraine LLC to enable a broadened distribution of OPRA Implant System in Ukraine1
19.05.INTEGRUM AB: Integrum signs commercial distribution agreement with Labormed for the Slovenian market1
05.05.Integrum AB appoints Martin Hillsten as new CEO1
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1